期刊
CURRENT DRUG METABOLISM
卷 22, 期 7, 页码 503-522出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389200222666210705122913
关键词
In silico; in vitro; ADMET profiling; drug discovery; predictive tools; molecular descriptors
Early stage ADMET profiling is crucial in drug development to avoid late-stage attrition. While in silico methods offer economic and fast prediction ability, combining them with in vitro and in vivo methods can enhance predictability.
In the drug discovery setting, undesirable ADMET properties of a pharmacophore with good predictive power obtained after a tedious drug discovery and development process may lead to late-stage attrition. The early stage ADMET profiling has brought a new dimension to lead drug development. Although several high-throughput in vitro models are available for ADMET profiling, the in silico methods are gaining more importance because of their economic and faster prediction ability without the requirements of tedious and expensive laboratory resources. Nonetheless, in silico ADMET tools alone are not accurate, and therefore, ideally adopted along with in vitro and or in vivo methods in order to enhance the predictability power. This review summarizes the significance and challenges associated with the application of in silico tools as well as the possible scope of in vitro models for integration to improve the ADMET predictability power of these tools.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据